Searching for "university" found 64

Tony Mok – Chair of the Department of Clinical Oncology, Chinese University of Hong Kong

Hong Kong Tony Mok – Chair of the Department of Clinical Oncology, Chinese University of Hong Kong

Hong Kong One of Asia’s most pre-eminent oncologists, Professor Tony Mok is perhaps best known for discovering the EGFR mutation gene and subsequently developing a targeted therapy that is more precise and personalized than standard chemotherapy. Here, Professor Mok discusses his current research areas of focus, some of the key clinical trial…

Paul Tam – Chair Professor & VP, Macau University of Science and Technology

Hong Kong Paul Tam – Chair Professor & VP, Macau University of Science and Technology

Hong Kong Paul Tam, who serves as chair professor & VP at Macau University of Science and Technology as well as emeritus professor and honorary clinical professor of surgery at the University of Hong Kong, has made important contributions to advances in paediatric minimal invasive surgery, genetics, and regenerative medicine of birth…

Turkey Pharma Roundup: New Omya API Site; Santa Farma 4th EU-GMP Certification; BioNTech/Koç University Collaboration

Turkey Turkey Pharma Roundup: New Omya API Site; Santa Farma 4th EU-GMP Certification; BioNTech/Koç University Collaboration

Turkey A roundup of the latest pharma and healthcare news from Turkey including Omya’s new Turkish manufacturing site, Santa Farma’s fourth EU-GMP certification and the collaboration agreement between BioNTech and Turkey’s Koç University. Omya production site in Turkey gains health authority approval (OutsourcingPharma) Swiss company, Omya, has gained official Turkish…

Dennis Lo – Associate Dean (Research); Li Ka Shing Professor of Medicine; Chairman, Department of Chemical Pathology; Director, Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong (CUHK)

Hong Kong Dennis Lo – Associate Dean (Research); Li Ka Shing Professor of Medicine; Chairman, Department of Chemical Pathology; Director, Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong (CUHK)

Hong Kong A groundbreaking research scientist noted for his work in non-invasive blood-based diagnoses, Professor Dennis Lo currently holds a number of positions at the Chinese University of Hong Kong (CUHK). Lo, whose work was first commercialised via the company Cirina – later acquired by GRAIL – outlines his current research focus on…

Michael Yang – Senior Vice-President (Innovation and Enterprise), City University of Hong Kong (CityU)

Hong Kong Michael Yang – Senior Vice-President (Innovation and Enterprise), City University of Hong Kong (CityU)

Hong Kong Professor Michael Yang of City University of Hong Kong (CityU) introduces the ‘HK Tech 300‘ programme he oversees, the largest university-based entrepreneurship programme in Asia. Drawing on his own experience as co-founder of Prenetics and Cellomics, biotech companies based on technologies developed in his laboratory at CityU, Professor Yang assesses…

Amel El Beshlawy – Professor of Paediatric Haematology, Paediatric Hospital of Cairo University

Egypt Amel El Beshlawy – Professor of Paediatric Haematology, Paediatric Hospital of Cairo University

Egypt Dr Amel El Beshlawy, founder of Egyptian Thalassemia Association (ETA) and Professor of Pediatric Hematology at the Pediatric Hospital of Cairo University, is considered the Middle East’s leading authority on Thalassemia, having made an enduring contribution not only to improving the survival rate of thalassemia patients in her clinical practice,…

Navin Pinto – Attending Physician, Seattle Children’s Hospital; Associate Professor of Paediatrics, University of Washington School of Medicine

USA Navin Pinto – Attending Physician, Seattle Children’s Hospital; Associate Professor of Paediatrics, University of Washington School of Medicine

USA Paediatric oncologist Navin Pinto, MD outlines the current use and potential of CAR-T therapies in his field, including the manufacturing challenges that still need to be addressed. Dr Pinto also explains how the work of his CAR-T team at the University of Washington School of Medicine could provide proof of…

Sam Volchenboum – Associate Professor of Pediatrics, Dean of Master’s Education, Associate Chief, Research Informatics Officer Associate Director, Institute for Translational Medicine, University of Chicago

USA Sam Volchenboum – Associate Professor of Pediatrics, Dean of Master’s Education, Associate Chief, Research Informatics Officer Associate Director, Institute for Translational Medicine, University of Chicago

USA Dr Sam Volchenboum outlines the progress that has been made in the paediatric oncology field in recent years and his hopes for its future. Dr Volchenboum also explains the important role that data will play in the new era of targeted and personalised therapies and the impact of the work…

Subra Suresh – President, Nanyang Technological University (NTU), Singapore

Singapore Subra Suresh – President, Nanyang Technological University (NTU), Singapore

Singapore Professor Subra Suresh, president of Nanyang Technological University (NTU) and former director of the US National Science Foundation, explains how the university has managed to consistently be among the top academic institutions in the world despite having only three decades of existence, and outlines Singapore’s strengths as an innovation, trade,…

Jørgen Schøler Kristensen – Chairman, Danish Medicines Council & Chief Medical Officer, Aarhus University Hospital

Denmark Jørgen Schøler Kristensen – Chairman, Danish Medicines Council & Chief Medical Officer, Aarhus University Hospital

Denmark Jørgen Schøler Kristensen explains the role of the Danish Medicines Council, providing guidance about new medicines for use in the Danish hospital sector. Kristensen also tackles the thorny issues of price considerations, assessing the long-term efficacy of innovative new therapies, and working collaboratively with private industry. There is a…

Ashok Venkitaraman – Director, Cancer Science Institute of Singapore; Distinguished Professor of Medicine, Yong Loo Lin School of Medicine, National University of Singapore (NUS); Director, NUS Center for Cancer Research; Program Director, Disease Intervention Technology Laboratory, Agency for Science, Technology & Research (A*STAR)

Singapore Ashok Venkitaraman – Director, Cancer Science Institute of Singapore; Distinguished Professor of Medicine, Yong Loo Lin School of Medicine, National University of Singapore (NUS); Director, NUS Center for Cancer Research; Program Director, Disease Intervention Technology Laboratory, Agency for Science, Technology & Research (A*STAR)

Singapore Professor Ashok Venkitaraman introduces his work in Singapore, coordinating and catalysing research on the causes of cancer in Asia, and translating this research to clinical impact through improved detection, treatment and prevention. Professor Venkitaraman also outlines how the Singaporean research ecosystem compares to that of his former base in Cambridge,…

Thomas D. Szucs, European Center of Pharmaceutical Medicine at the University of Basel; Hirslanden Private Hospital, Switzerland; Chairman, Helsana Group

Switzerland Thomas D. Szucs, European Center of Pharmaceutical Medicine at the University of Basel; Hirslanden Private Hospital, Switzerland; Chairman, Helsana Group

Switzerland Genomic medicine expert Professor Thomas D. Szucs explains what ignited his interest in the field and how payers and authorities are adapting to the strain on resources that genomic medicine can contribute to. Professor Szucs also evaluates the sustainability of personalized medicine and China’s rapid progress in the field. …

1 2 … 6